Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00469339 · ClinicalTrials.gov registry record

Risk Communication Within Mexican-American Families

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
498
Enrollment target

NCT00469339: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00469339 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 498 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00469339 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
498 participants
Enrollment target

Study Summary

This study will examine what methods work best for encouraging Mexican-American family members to talk about their risk for diabetes, heart disease, breast cancer and colon cancer. Within the Mexican-American community, the family culture provides an important setting in which individuals interpret and share their health information and formulate strategies to engage in health-promoting behaviors. The information from the study will be used to design risk communication approaches for Mexican-American households. Members of households with at least three adults 18 to 70 years of age who are part of the existing Mexican-American households recruited by the University of Texas M.D. Anderson Cancer Center may be eligible for this study. Participants are interviewed about their medical history, family history of disease, health behaviors, beliefs about disease and disease risk, experiences living in the United States, and relationships with family members and close friends. They are then provided information about their family risk for diabetes, heart disease, breast cancer and colon cancer, based on the information they provided in the interview. Two additional interviews are conducted over the telephone that include questions about how the participants communicate with family members about their risk and health behaviors.

Primary Outcome

Understand how culture and the familial social system facilitate or impede communications regarding family health history and risk for disease, and the development of strategies to adopt health promoting behaviors.

Interventions

  • BEHAVIORAL Family Health History

Trial Details

FieldValue
Enrollment Target 498 participants
Start Date 2007-04-27

What the finished NCT00469339 record still lists

NCT00469339 is an observational study that tracks outcomes without assigning an intervention. The registered 498 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Family Health History is the first listed.

NCT00469339 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00469339 about?

NCT00469339 is a clinical study titled "Risk Communication Within Mexican-American Families". This study will examine what methods work best for encouraging Mexican-American family members to talk about their risk for diabetes, heart disease, breast cancer and colon cancer. Within the Mexican-American community, the family culture provides an important setting in which individuals interpret ...

What is the current status of trial NCT00469339?

This trial is currently completed. The enrollment target is 498 participants. The study started on 2007-04-27.

What interventions are being tested in trial NCT00469339?

The interventions under investigation include: Family Health History (BEHAVIORAL).

Who is sponsoring clinical trial NCT00469339?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04137900 · 499 participants · Phase 1

    Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

  • NCT06733480 · 499 participants · NA

    Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue

  • NCT03175224 · 497 participants · Phase 2

    APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • NCT05301816 · 497 participants · NA

    PDN Post Market, Multicenter, Prospective, Global Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00469339, the US trial registry maintained by the National Library of Medicine. NCT00469339 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.